Logo image of 1ALAB.MI

ASTERA LABS INC (1ALAB.MI) Stock Fundamental Analysis

Europe - Euronext Milan - BIT:1ALAB - US04626A1034 - Common Stock

143 EUR
-2 (-1.38%)
Last: 1/5/2026, 7:00:00 PM
Fundamental Rating

4

Overall 1ALAB gets a fundamental rating of 4 out of 10. We evaluated 1ALAB against 65 industry peers in the Semiconductors & Semiconductor Equipment industry. No worries on liquidiy or solvency for 1ALAB as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, 1ALAB is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year 1ALAB was profitable.
1ALAB had a positive operating cash flow in the past year.
1ALAB.MI Yearly Net Income VS EBIT VS OCF VS FCF1ALAB.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

1ALAB has a better Return On Assets (14.19%) than 80.70% of its industry peers.
The Return On Equity of 1ALAB (15.64%) is comparable to the rest of the industry.
1ALAB's Return On Invested Capital of 6.15% is in line compared to the rest of the industry. 1ALAB outperforms 49.12% of its industry peers.
Industry RankSector Rank
ROA 14.19%
ROE 15.64%
ROIC 6.15%
ROA(3y)-16.28%
ROA(5y)N/A
ROE(3y)-19.89%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1ALAB.MI Yearly ROA, ROE, ROIC1ALAB.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -10 -20 -30

1.3 Margins

Looking at the Profit Margin, with a value of 27.50%, 1ALAB is in the better half of the industry, outperforming 75.44% of the companies in the same industry.
1ALAB has a Operating Margin (14.74%) which is comparable to the rest of the industry.
Looking at the Gross Margin, with a value of 75.41%, 1ALAB belongs to the top of the industry, outperforming 94.74% of the companies in the same industry.
Industry RankSector Rank
OM 14.74%
PM (TTM) 27.5%
GM 75.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
1ALAB.MI Yearly Profit, Operating, Gross Margins1ALAB.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 50 -50

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 1ALAB is destroying value.
1ALAB has more shares outstanding than it did 1 year ago.
There is no outstanding debt for 1ALAB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
1ALAB.MI Yearly Shares Outstanding1ALAB.MI Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 50M 100M 150M
1ALAB.MI Yearly Total Debt VS Total Assets1ALAB.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 136.05 indicates that 1ALAB is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 136.05, 1ALAB belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
1ALAB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 136.05
ROIC/WACC0.57
WACC10.85%
1ALAB.MI Yearly LT Debt VS Equity VS FCF1ALAB.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

1ALAB has a Current Ratio of 12.78. This indicates that 1ALAB is financially healthy and has no problem in meeting its short term obligations.
1ALAB has a better Current ratio (12.78) than 98.25% of its industry peers.
A Quick Ratio of 12.27 indicates that 1ALAB has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 12.27, 1ALAB belongs to the top of the industry, outperforming 98.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 12.78
Quick Ratio 12.27
1ALAB.MI Yearly Current Assets VS Current Liabilites1ALAB.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

1ALAB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -269.05%.
Looking at the last year, 1ALAB shows a very strong growth in Revenue. The Revenue has grown by 242.24%.
EPS 1Y (TTM)-269.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%113.04%
Revenue 1Y (TTM)242.24%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%103.89%

3.2 Future

The Earnings Per Share is expected to grow by 35.05% on average over the next years. This is a very strong growth
1ALAB is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 38.28% yearly.
EPS Next Y81.15%
EPS Next 2Y54.88%
EPS Next 3Y48.21%
EPS Next 5Y35.05%
Revenue Next Year118.34%
Revenue Next 2Y77.69%
Revenue Next 3Y62.33%
Revenue Next 5Y38.28%

3.3 Evolution

1ALAB.MI Yearly Revenue VS Estimates1ALAB.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
1ALAB.MI Yearly EPS VS Estimates1ALAB.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 1 2 3 4

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 102.88, 1ALAB can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of 1ALAB indicates a rather expensive valuation: 1ALAB more expensive than 82.46% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.92, 1ALAB is valued quite expensively.
With a Price/Forward Earnings ratio of 70.04, 1ALAB can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, 1ALAB is valued more expensive than 87.72% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.57. 1ALAB is valued rather expensively when compared to this.
Industry RankSector Rank
PE 102.88
Fwd PE 70.04
1ALAB.MI Price Earnings VS Forward Price Earnings1ALAB.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, 1ALAB is valued expensively inside the industry as 92.98% of the companies are valued cheaper.
1ALAB's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. 1ALAB is more expensive than 68.42% of the companies in the same industry.
Industry RankSector Rank
P/FCF 123.69
EV/EBITDA 240.63
1ALAB.MI Per share data1ALAB.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

1ALAB's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
1ALAB's earnings are expected to grow with 48.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.27
PEG (5Y)N/A
EPS Next 2Y54.88%
EPS Next 3Y48.21%

0

5. Dividend

5.1 Amount

No dividends for 1ALAB!.
Industry RankSector Rank
Dividend Yield 0%

ASTERA LABS INC

BIT:1ALAB (1/5/2026, 7:00:00 PM)

143

-2 (-1.38%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-04 2025-11-04/amc
Earnings (Next)02-09 2026-02-09/amc
Inst Owners76.83%
Inst Owner ChangeN/A
Ins Owners11.28%
Ins Owner ChangeN/A
Market Cap24.15B
Revenue(TTM)723.04M
Net Income(TTM)198.87M
Analysts81.54
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)28.26%
Min EPS beat(2)23.34%
Max EPS beat(2)33.19%
EPS beat(4)4
Avg EPS beat(4)27.63%
Min EPS beat(4)13.95%
Max EPS beat(4)40.06%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)9.25%
Min Revenue beat(2)9.05%
Max Revenue beat(2)9.44%
Revenue beat(4)4
Avg Revenue beat(4)7.16%
Min Revenue beat(4)2.08%
Max Revenue beat(4)9.44%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 102.88
Fwd PE 70.04
P/S 39.25
P/FCF 123.69
P/OCF 107.6
P/B 22.32
P/tB 22.32
EV/EBITDA 240.63
EPS(TTM)1.39
EY0.97%
EPS(NY)2.04
Fwd EY1.43%
FCF(TTM)1.16
FCFY0.81%
OCF(TTM)1.33
OCFY0.93%
SpS3.64
BVpS6.41
TBVpS6.41
PEG (NY)1.27
PEG (5Y)N/A
Graham Number14.16
Profitability
Industry RankSector Rank
ROA 14.19%
ROE 15.64%
ROCE 8.2%
ROIC 6.15%
ROICexc 48.23%
ROICexgc 48.23%
OM 14.74%
PM (TTM) 27.5%
GM 75.41%
FCFM 31.73%
ROA(3y)-16.28%
ROA(5y)N/A
ROE(3y)-19.89%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 692.01%
Cap/Sales 4.74%
Interest Coverage 250
Cash Conversion 236.4%
Profit Quality 115.38%
Current Ratio 12.78
Quick Ratio 12.27
Altman-Z 136.05
F-Score8
WACC10.85%
ROIC/WACC0.57
Cap/Depr(3y)573.57%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.29%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-269.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%113.04%
EPS Next Y81.15%
EPS Next 2Y54.88%
EPS Next 3Y48.21%
EPS Next 5Y35.05%
Revenue 1Y (TTM)242.24%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%103.89%
Revenue Next Year118.34%
Revenue Next 2Y77.69%
Revenue Next 3Y62.33%
Revenue Next 5Y38.28%
EBIT growth 1Y-293.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year240.9%
EBIT Next 3Y91.65%
EBIT Next 5Y56.74%
FCF growth 1Y761.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1174.83%
OCF growth 3YN/A
OCF growth 5YN/A

ASTERA LABS INC / 1ALAB.MI FAQ

Can you provide the ChartMill fundamental rating for ASTERA LABS INC?

ChartMill assigns a fundamental rating of 4 / 10 to 1ALAB.MI.


Can you provide the valuation status for ASTERA LABS INC?

ChartMill assigns a valuation rating of 1 / 10 to ASTERA LABS INC (1ALAB.MI). This can be considered as Overvalued.


Can you provide the profitability details for ASTERA LABS INC?

ASTERA LABS INC (1ALAB.MI) has a profitability rating of 3 / 10.


What is the earnings growth outlook for ASTERA LABS INC?

The Earnings per Share (EPS) of ASTERA LABS INC (1ALAB.MI) is expected to grow by 81.15% in the next year.